Chemoinformaics analysis of 3,4,5-TRI-O-GALLOYLSHIKIMIC-ACID
| Molecular Weight | 630.467 | nRot | 7 |
| Heavy Atom Molecular Weight | 608.291 | nRig | 28 |
| Exact Molecular Weight | 630.086 | nRing | 4 |
| Solubility: LogS | -2.639 | nHRing | 0 |
| Solubility: LogP | 1.529 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 3 |
| nHetero | 17 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 17 | No. of Arom Bond | 18 |
| nHA | 16 | APOL | 75.0634 |
| nHD | 10 | BPOL | 30.7506 |
| QED | 0.1 |
| Synth | 4.154 |
| Natural Product Likeliness | 0.925 |
| NR-PPAR-gamma | 0.302 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0 |
| HIA | 0.992 |
| CACO-2 | -6.81 |
| MDCK | 0.00000745 |
| BBB | 0.014 |
| PPB | 0.85617 |
| VDSS | 0.412 |
| FU | 0.159185 |
| CYP1A2-inh | 0.465 |
| CYP1A2-sub | 0.008 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.019 |
| CYP2c9-inh | 0.489 |
| CYP2c9-sub | 0.031 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.076 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.013 |
| CL | 11.953 |
| T12 | 0.985 |
| hERG | 0.018 |
| Ames | 0.019 |
| ROA | 0.002 |
| SkinSen | 0.951 |
| Carcinogencity | 0.028 |
| EI | 0.92 |
| Respiratory | 0.007 |
| NR-Aromatase | 0.233 |
| Antiviral | Yes |
| Prediction | 0.745248 |